D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Resources Connection
RGP
$159M
| $179K | ﹤0.01% |
48,034
-162,910
| -77% | -$667K |
|
4127
Lexeo Therapeutics
LXEO
$368M
| $175K | ﹤0.01% |
30,477
-449,728
| -94% | -$3.19M |
|
4128
PUT
Alight
ALIT
$573M
| $175K | ﹤0.01% |
15,000
+10,000
| +200% | +$238K |
|
|
TTAM
4129
Titan America SA
TTAM
$3.12B
| $174K | ﹤0.01% |
+11,584
| New | +$198K |
|
|
BRT
4130
BRT Apartments
BRT
$280M
| $172K | ﹤0.01% |
+12,864
| New | +$187K |
|
|
KC
4131
Kingsoft Cloud Holdings
KC
$2.86B
| $171K | ﹤0.01% |
12,828
-348,772
| -96% | -$4.56M |
|
4132
Ironwood Pharmaceuticals
IRWD
$635M
| $168K | ﹤0.01% |
47,938
-69,508
| -59% | -$285K |
|
4133
Ginkgo Bioworks
DNA
$517M
| $167K | ﹤0.01% |
27,169
-6,603
| -20% | -$54.9K |
|
4134
PUT
AGNC Investment
AGNC
$12.9B
| $166K | ﹤0.01% |
+16,600
| New | +$184K |
|
|
AGMB
4135
AgomAb Therapeutics NV
AGMB
$593M
| $161K | ﹤0.01% |
+15,326
| New | +$217K |
|
4136
Clover Health Investments
CLOV
$2.43B
| $160K | ﹤0.01% |
91,011
-191,679
| -68% | -$416K |
|
4137
Schrodinger
SDGR
$1.14B
| $160K | ﹤0.01% |
+14,041
| New | +$194K |
|
4138
Independence Realty Trust
IRT
$3.92B
| $159K | ﹤0.01% |
+10,645
| New | +$175K |
|
|
BPAC
4139
Blueport Acquisition Ltd
BPAC
$74.9M
| $156K | ﹤0.01% |
+15,610
| New | +$156K |
|
4140
BCB Bancorp
BCBP
$179M
| $154K | ﹤0.01% |
17,174
-18,421
| -52% | -$151K |
|
4141
Similarweb
SMWB
$610M
| $153K | ﹤0.01% |
58,552
+30,176
| +106% | +$126K |
|
|
FSP
4142
Franklin Street Properties
FSP
$51.3M
| $151K | ﹤0.01% |
227,035
-584,654
| -72% | -$452K |
|
|
PMTRW
4143
Perimeter Acquisition Corp I Warrant
PMTRW
$11.5M
| $150K | ﹤0.01% |
250,000
| – | – |
|
|
ATIIW
4144
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$21.5M
| $147K | ﹤0.01% |
287,500
| – | – |
|
4145
Forrester Research
FORR
$200M
| $146K | ﹤0.01% |
25,811
-96,513
| -79% | -$660K |
|
|
ADAM
4146
Adamas Trust
ADAM
$807M
| $145K | ﹤0.01% |
+19,732
| New | +$157K |
|
4147
Verastem
VSTM
$530M
| $141K | ﹤0.01% |
26,659
-312,194
| -92% | -$1.93M |
|
4148
Recursion Pharmaceuticals
RXRX
$1.56B
| $141K | ﹤0.01% |
46,008
-43,536
| -49% | -$168K |
|
|
LMRI
4149
Lumexa Imaging Holdings
LMRI
$1.07B
| $141K | ﹤0.01% |
16,418
-183,582
| -92% | -$2.52M |
|
4150
MaxCyte
MXCT
$133M
| $141K | ﹤0.01% |
200,505
-463,451
| -70% | -$433K |
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.